ERK1/2 activation in endothelial cells with upregulation of c-Fos, c-Jun, and Egr-1, regulating cell proliferation and vascular tube formation in vitro
Improved Gut Barrier Function: BPC-157 strengthens tight junction proteins that maintain intestinal barrier integrity
Many of these substances were designated as Category 2 substances on the FDAs interim 503A Bulks List in 2023, reflecting the FDAs preliminary determination that they presented significant safety risks in the context of compounding
Individuals recovering from surgery or injury
WADA Prohibition The World Anti-Doping Agency classifies both peptides as prohibited substances: Both listed under Section S0 (Non-Approved Substances) Prohibited at all times (in and out of competition) No Therapeutic Use Exemptions (TUEs) available for either peptide Detection methods under development for anti-doping testing TB-500 and thymosin beta-4 explicitly banned since 2011 WADAs position reflects that neither peptide has regulatory approval from any health authority worldwide
Sermorelin is not a direct weight-loss medication, but it may support weight loss indirectly for some people
